In the LPS-induced endotoxemia model, our data indicate that knockout of Scd-1 exacerbates endotoxemia symptoms and enhances the inflammatory response, while pretreatment with OA can alleviate symptoms and reduce inflammation levels. The gene discussed is SCD; the disease is serum lipopolysaccharide activity.